정밀의료 소프트웨어 시장 규모, 점유율과 동향 분석 리포트 : 컴포넌트별, 배포별, 용도별, 기술별, 치료 영역별, 최종 용도별, 지역별, 부문 예측(2025-2033년)
Precision Medicine Software Market Size, Share & Trends Analysis Report By Component, By Deployment, By Application, By Technology, By Therapeutic Area, By End Use, By Region, And Segment Forecasts, 2025 - 2033
상품코드
:
1869706
리서치사
:
Grand View Research
발행일
:
2025년 10월
페이지 정보
:
영문 100 Pages
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
샘플 요청 목록에 추가
정밀의료 소프트웨어 시장 요약
세계의 정밀의료 소프트웨어 시장 규모는 2024년에 21억 2,000만 달러로 평가되며, 2033년까지 56억 6,000만 달러에 달할 것으로 예측됩니다.
2025-2033년에 CAGR 11.8%로 성장할 전망입니다. 이러한 성장은 유전체 시퀀싱의 비용 감소, 표적 치료 및 맞춤 치료의 확산, 분산형 임상시험 증가, 그리고 리얼 월드 데이터(RWE)의 활용에 기인합니다.
또한 유전체학 및 정밀의료를 지원하는 정부 및 기관의 노력과 개인 의료에 대한 수요는 업계 전망을 더욱 밝게 하고 있습니다. 유전체 시퀀싱의 비용 감소로 인해 고비용의 연구 전용 툴였던 유전체 시퀀싱이 임상 실습의 일상적인 부분으로 변모하면서 정밀의료 소프트웨어 산업의 주요 동력이 되고 있습니다. 2000년대 초에는 유전체 1건당 약 1억 달러가 소요되던 것이 현재는 500달러 미만으로 가능해져 병원, 진단검사실, 제약회사, 컨슈머 헬스케어 기업에서 광범위하게 도입할 수 있게 되었습니다.
이러한 저렴한 가격으로 인해 대규모 게놈 검사가 급증하면서 저장, 통합 및 해석을 위해 고급 소프트웨어가 필요한 방대한 데이터세트가 생성되고 있습니다. 정밀의료 소프트웨어는 이 원시 데이터(시퀀싱 데이터)를 진단, 치료 선택, 환자 분류를 위한 실용적인 임상 지식으로 변환하는 핵심적인 역할을 하고 있으며, 종양학, 희귀질환 치료, 예방의학에서 시퀀싱이 표준화됨에 따라 수요를 견인하고 있습니다.
목차 제1장 조사 방법과 범위
제2장 개요
제3장 시장 변수, 동향, 범위
시장 계통 전망
시장 역학
시장 성장 촉진요인 분석
시장 성장 억제요인 분석
업계 기회 분석
업계의 과제 분석
테크놀러지 개요
사례 연구
비즈니스 환경 분석
Porter's Five Forces 분석
PESTLE 분석
제4장 정밀의료 소프트웨어 시장 : 컴포넌트 추정·동향 분석
컴포넌트 부문 대시보드
컴포넌트 시장 점유율 변동 분석, 2024년 및 2033년
시장 규모, 예측, 동향 분석(컴포넌트별, 2021-2033년)
소프트웨어
서비스
실장과 통합
임상 통역 및 보고 서비스
검증과 규제 지원
데이터 큐레이션/어노테이션 서비스
기타
제5장 정밀의료 소프트웨어 시장 : 배포 모드 추정·동향 분석
배포 모드 대시보드
배포 모드 시장 점유율 변동 분석, 2024년 및 2033년
시장 규모, 예측, 동향 분석, 배포 모드별, 2021-2033년
클라우드 기반
온프레미스
제6장 정밀의료 소프트웨어 시장 : 용도 추정·동향 분석
용도 부문 대시보드
용도 시장 점유율 변동 분석, 2024년 및 2033년
시장 규모, 예측, 동향 분석(용도별, 2021-2033년)
게놈 데이터 관리 및 분석
멀티오믹스 분석
임상 의사결정 지원과 치료 계획
동반진단 및 바이오마커 발견 툴
임상시험 매칭과 시행 시설 선택
기타(집단 유전체학/공중위생 정밀 툴)
제7장 정밀의료 소프트웨어 시장 : 기술 추정·동향 분석
기술 대시보드
기술 시장 점유율 변동 분석, 2024년 및 2033년
시장 규모, 예측, 동향 분석(기술별, 2021-2033년)
AI/기계학습 모델과 생성형 AI
룰 기반 엔진(임상 가이드라인, 패스웨이)
클라우드와 컨테이너화 파이프라인(Kubernetes/Docker)
유전체학을 위한 고성능 컴퓨팅/HPC
상호운용성/FHIR/HL7 통합
기타(데이터 레이크와 MDM(멀티모달 데이터 스토어))
제8장 정밀의료 소프트웨어 시장 : 치료 영역 추정·동향 분석
치료 영역 대시보드
치료 영역 시장 점유율 변동 분석, 2024년 및 2033년
시장 규모, 예측, 동향 분석(치료 영역별, 2021-2033년)
종양학
심장병학
신경학/중추신경계
희귀질환 및 유전성 질환
감염증(병원체 유전체학)
면역학/자가면역
기타(피부과, 내분비과)
제9장 정밀의료 소프트웨어 시장 : 최종 용도 추정·동향 분석
최종 용도 부문 대시보드
최종 용도 시장 점유율 변동 분석, 2024년 및 2033년
시장 규모, 예측, 동향 분석(최종 용도별, 2021-2033년)
병원
제약·바이오테크놀러지 기업
진단 실험실 및 게놈 서비스 프로바이더
수탁 연구기관(CRO)
기타(연구기관·학술 센터)
제10장 정밀의료 소프트웨어 시장 : 지역 추정·동향 분석
지역 시장 대시보드
지역 시장 : 주요 포인트
북미
유럽
독일
영국
프랑스
이탈리아
스페인
덴마크
스웨덴
노르웨이
아시아태평양
라틴아메리카
중동 및 아프리카
남아프리카공화국
사우디아라비아
아랍에미리트
쿠웨이트
제11장 경쟁 구도
참가자 개요
기업 시장 현황 분석/기업 시장 점유율 분석(2024년)
기업 분류
전략 지도제작
기업 개요
OSP
Genomind
IQVIA
Genedata AG
SOPHiA GENETICS
Tempus AI, Inc.
Owkin, Inc.
Syapse(acquired by N-Power in January 2025)
Inspirata, Inc.
Precision Medicine Group, LLC.
Siemens
GenomOncology LLC
Qserve
Foundation Medicine, Inc.
PierianDx
KSA
영문 목차
Precision Medicine Software Market Summary
The global precision medicine software market size was valued at USD 2.12 billion in 2024 and is projected to reach USD 5.66 billion by 2033, growing at a CAGR of 11.8% from 2025 to 2033. This growth is attributed to declining cost of genome sequencing, rise of targeted and personalized therapies, the increase of decentralized trials, and real-world evidence.
Moreover, government and institutional initiatives supporting genomics and precision medicine, and demand for personalized healthcare, have fueled the industry outlook. The declining cost of genome sequencing has transformed it from a high-cost, research-only tool into a routine part of clinical practice, making it a key driver of the precision medicine software industry. What once cost nearly USD 100 million per genome in the early 2000s can now be performed for under USD 500, enabling widespread adoption by hospitals, diagnostic labs, pharmaceutical companies, and even consumer health firms.
This affordability has led to a surge in large-scale genomic testing, generating massive datasets that require advanced software for storage, integration, and interpretation. Precision medicine software plays a central role in converting this raw sequencing data into actionable clinical insights for diagnosis, therapy selection, and patient stratification, driving demand as sequencing becomes standard in oncology, rare disease treatment, and preventive healthcare.
Global Precision Medicine Software Market Report Segmentation
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global precision medicine software market report based on component, deployment mode, application, technology, therapeutic area, end use and region.
Component Outlook (Revenue, USD Million, 2021 - 2033)
Software
Services
Implementation & integration
Clinical interpretation & reporting services
Validation & regulatory support
Data curation / annotation services
Others
Deployment Mode Outlook (Revenue, USD Million, 2021 - 2033)
Cloud-based
On-premise
Application Outlook (Revenue, USD Million, 2021 - 2033)
Genomic Data Management & Analysis
Multi-omics Analytics
Clinical Decision Support & Treatment Planning
Companion Diagnostics & Biomarker Discovery Tools
Clinical Trial Matching & Site Selection
Others (Population Genomics / Public-health Precision Tools)
Technology Outlook (Revenue, USD Million, 2021 - 2033)
AI / Machine Learning models & Generative AI
Rule-based engines (clinical guidelines, pathways)
Cloud & Containerized Pipelines (Kubernetes/Docker)
High-performance compute / HPC for genomics
Interoperability / FHIR / HL7 integration
Others (Data lakes & MDM (multi-modal data stores))
Therapeutic Area Outlook (Revenue, USD Million, 2021 - 2033)
Oncology
Cardiology
Neurology / CNS
Rare & Genetic Disorders
Infectious Diseases (pathogen genomics)
Immunology / Autoimmune
Others (dermatology, endocrinology)
End Use Outlook (Revenue, USD Million, 2021 - 2033)
Hospitals
Pharmaceutical & Biotech companies
Diagnostic Laboratories & Genomic Service Providers
Contract Research Organizations (CROs)
Others (Research Institutes & Academic Centers)
Regional Outlook (Revenue, USD Million, 2021 - 2033)
North America
Europe
UK
Germany
France
Italy
Spain
Denmark
Sweden
Norway
Asia Pacific
China
Japan
India
South Korea
Australia
Thailand
Latin America
Middle East and Africa (MEA)
South Africa
Saudi Arabia
UAE
Kuwait
Table of Contents Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Component
1.2.2. Deployment Mode
1.2.3. Application
1.2.4. Technology
1.2.5. Therapeutic Area
1.2.6. End Use
1.3. Estimates and Forecast Timeline
1.4. Research Methodology
1.5. Information Procurement
1.5.1. Purchased Database
1.5.2. GVR's Internal Database
1.5.3. Secondary Sources
1.5.4. Primary Research
1.6. Information Analysis
1.6.1. Data Analysis Models
1.7. Market Formulation & Data Visualization
1.8. Model Details
1.8.1. Commodity Flow Analysis
1.9. List of Secondary Sources
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Snapshot
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
Chapter 3. Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.1.1. Declining Cost of Genome Sequencing
3.2.1.2. Shift toward value-based and personalized care
3.2.1.3. Government and institutional initiatives supporting genomics and precision medicine
3.2.1.4. Rising patient awareness and demand for personalized healthcare
3.2.1.5. Maturing interoperability standards (FHIR, GA4GH, HL7)
3.2.1.6. Advances in AI and machine learning
3.2.2. Market Restraint Analysis
3.2.2.1. High implementation and maintenance costs
3.2.2.2. Integration challenges with legacy electronic health records
3.2.2.3. Shortage of skilled professionals in bioinformatics, genomics, and data science.
3.2.3. Industry Opportunity Analysis
3.2.4. Industry Challenge Analysis
3.2.5. Technology Overview
3.2.6. Case Studies
3.3. Business Environment Analysis
3.3.1. Porter's Five Forces Analysis
3.3.1.1. Supplier power
3.3.1.2. Buyer power
3.3.1.3. Substitution threat
3.3.1.4. Threat of new entrant
3.3.1.5. Competitive rivalry
3.3.2. PESTLE Analysis
3.3.2.1. Political landscape
3.3.2.2. Economic and Social landscape
3.3.2.3. Technological landscape
3.3.2.4. Environmental landscape
3.3.2.5. Legal Landscape
Chapter 4. Precision Medicine Software Market: Component Estimates & Trend Analysis
4.1. Component Segment Dashboard
4.2. Component Market Share Movement Analysis, 2024 & 2033
4.3. Market Size & Forecasts and Trend Analysis, by Component, 2021 to 2033 (USD Million)
4.4. Software
4.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.5. Services
4.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.5.2. Implementation & integration
4.5.2.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.5.3. Clinical interpretation & reporting services
4.5.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.5.4. Validation & regulatory support
4.5.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.5.5. Data curation / annotation services
4.5.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.5.6. Others
4.5.6.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 5. Precision Medicine Software Market: Deployment Mode Estimates & Trend Analysis
5.1. Deployment Mode Dashboard
5.2. Deployment Mode Market Share Movement Analysis, 2024 & 2033
5.3. Market Size & Forecasts and Trend Analysis, by Deployment Mode, 2021 to 2033 (USD Million)
5.4. Cloud Based
5.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
5.5. On-Premise
5.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 6. Precision Medicine Software Market: Application Estimates & Trend Analysis
6.1. Application Segment Dashboard
6.2. Application Market Share Movement Analysis, 2024 & 2033
6.3. Market Size & Forecasts and Trend Analysis, by Application, 2021 to 2033 (USD Million)
6.4. Genomic Data Management & Analysis
6.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
6.5. Multi-omics Analytics
6.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
6.6. Clinical Decision Support & Treatment Planning
6.6.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
6.7. Companion Diagnostics & Biomarker Discovery Tools
6.7.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
6.8. Clinical Trial Matching & Site Selection
6.8.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
6.9. Others (Population Genomics / Public-health Precision Tools)
6.9.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 7. Precision Medicine Software Market: Technology Estimates & Trend Analysis
7.1. Technology Dashboard
7.2. Technology Market Share Movement Analysis, 2024 & 2033
7.3. Market Size & Forecasts and Trend Analysis, by Technology, 2021 to 2033 (USD Million)
7.4. AI / Machine Learning models & Generative AI
7.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
7.5. Rule-based engines (clinical guidelines, pathways)
7.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
7.6. Cloud & Containerized Pipelines (Kubernetes/Docker)
7.6.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
7.7. High-performance compute / HPC for genomics
7.7.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
7.8. Interoperability / FHIR / HL7 integration
7.8.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
7.9. Others (Data lakes & MDM (multi-modal data stores))
7.9.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 8. Precision Medicine Software Market: Therapeutic Area Estimates & Trend Analysis
8.1. Therapeutic Area Dashboard
8.2. Therapeutic Area Market Share Movement Analysis, 2024 & 2033
8.3. Market Size & Forecasts and Trend Analysis, by Therapeutic Area, 2021 to 2033 (USD Million)
8.4. Oncology
8.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
8.5. Cardiology
8.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
8.6. Neurology / CNS
8.6.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
8.7. Rare & Genetic Disorders
8.7.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
8.8. Infectious Diseases (pathogen genomics)
8.8.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
8.9. Immunology / Autoimmune
8.9.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
8.10. Others (dermatology, endocrinology)
8.10.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 9. Precision Medicine Software Market: End Use Estimates & Trend Analysis
9.1. End Use Segment Dashboard
9.2. End Use Market Share Movement Analysis, 2024 & 2033
9.3. Market Size & Forecasts and Trend Analysis, by End Use, 2021 to 2033 (USD Million)
9.4. Hospitals
9.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
9.5. Pharmaceutical & Biotech companies
9.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
9.6. Diagnostic Laboratories & Genomic Service Providers
9.6.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
9.7. Contract Research Organizations (CROs)
9.7.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
9.8. Others (Research Institutes & Academic Centers)
9.8.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 10. Precision Medicine Software Market: Regional Estimates & Trend Analysis
10.1. Regional Market Dashboard
10.2. Regional Market: Key Takeaways
10.3. North America
10.3.1. North America Precision Medicine Software market estimates and forecasts, 2021 - 2033 (USD Million)
10.3.2. U.S.
10.3.2.1. Key country dynamic
10.3.2.2. Regulatory framework
10.3.2.3. Competitive insights
10.3.2.4. U.S. Precision Medicine Software market estimates and forecasts, 2021 - 2033 (USD Million)
10.3.3. Canada
10.3.3.1. Key country dynamic
10.3.3.2. Regulatory framework
10.3.3.3. Competitive insights
10.3.3.4. Canada Precision Medicine Software market estimates and forecasts, 2021 - 2033 (USD Million)
10.3.4. Mexico
10.3.4.1. Key country dynamic
10.3.4.2. Regulatory framework
10.3.4.3. Competitive insights
10.3.4.4. Mexico Precision Medicine Software market estimates and forecasts, 2021 - 2033 (USD Million)
10.4. Europe
10.4.1. Europe Precision Medicine Software market estimates and forecasts, 2021 - 2033 (USD Million)
10.4.2. Germany
10.4.2.1. Key country dynamic
10.4.2.2. Regulatory framework
10.4.2.3. Competitive insights
10.4.2.4. Germany Precision Medicine Software market estimates and forecasts, 2021 - 2033 (USD Million)
10.4.3. UK
10.4.3.1. Key country dynamic
10.4.3.2. Regulatory framework
10.4.3.3. Competitive insights
10.4.3.4. UK Precision Medicine Software market estimates and forecasts, 2021 - 2033 (USD Million)
10.4.4. France
10.4.4.1. Key country dynamic
10.4.4.2. Regulatory framework
10.4.4.3. Competitive insights
10.4.4.4. France Precision Medicine Software market estimates and forecasts, 2021 - 2033 (USD Million)
10.4.5. Italy
10.4.5.1. Key country dynamic
10.4.5.2. Regulatory framework
10.4.5.3. Competitive insights
10.4.5.4. Italy Precision Medicine Software market estimates and forecasts, 2021 - 2033 (USD Million)
10.4.6. Spain
10.4.6.1. Key country dynamic
10.4.6.2. Regulatory framework
10.4.6.3. Competitive insights
10.4.6.4. Spain Precision Medicine Software market estimates and forecasts, 2021 - 2033 (USD Million)
10.4.7. Denmark
10.4.7.1. Key country dynamic
10.4.7.2. Regulatory framework
10.4.7.3. Competitive insights
10.4.7.4. Denmark Precision Medicine Software market estimates and forecasts, 2021 - 2033 (USD Million)
10.4.8. Sweden
10.4.8.1. Key country dynamic
10.4.8.2. Regulatory framework
10.4.8.3. Competitive insights
10.4.8.4. Sweden Precision Medicine Software market estimates and forecasts, 2021 - 2033 (USD Million)
10.4.9. Norway
10.4.9.1. Key country dynamic
10.4.9.2. Regulatory framework
10.4.9.3. Competitive insights
10.4.9.4. Norway Precision Medicine Software market estimates and forecasts, 2021 - 2033 (USD Million)
10.5. Asia Pacific
10.5.1. Asia Pacific Precision Medicine Software market estimates and forecasts, 2021 - 2033 (USD Million)
10.5.2. Japan
10.5.2.1. Key country dynamic
10.5.2.2. Regulatory framework
10.5.2.3. Competitive insights
10.5.2.4. Japan Precision Medicine Software market estimates and forecasts, 2021 - 2033 (USD Million)
10.5.3. China
10.5.3.1. Key country dynamic
10.5.3.2. Regulatory framework
10.5.3.3. Competitive insights
10.5.3.4. China Precision Medicine Software market estimates and forecasts, 2021 - 2033 (USD Million)
10.5.4. India
10.5.4.1. Key country dynamic
10.5.4.2. Regulatory framework
10.5.4.3. Competitive insights
10.5.4.4. India Precision Medicine Software market estimates and forecasts, 2021 - 2033 (USD Million)
10.5.5. South Korea
10.5.5.1. Key country dynamic
10.5.5.2. Regulatory framework
10.5.5.3. Competitive insights
10.5.5.4. South Korea Precision Medicine Software market estimates and forecasts, 2021 - 2033 (USD Million)
10.5.6. Australia
10.5.6.1. Key country dynamic
10.5.6.2. Regulatory framework
10.5.6.3. Competitive insights
10.5.6.4. Australia Precision Medicine Software market estimates and forecasts, 2021 - 2033 (USD Million)
10.5.7. Thailand
10.5.7.1. Key country dynamic
10.5.7.2. Regulatory framework
10.5.7.3. Competitive insights
10.5.7.4. Thailand Precision Medicine Software market estimates and forecasts, 2021 - 2033 (USD Million)
10.6. Latin America
10.6.1. Latin America Precision Medicine Software Market Estimates and Forecasts, 2021 - 2033 (USD Million)
10.6.2. Brazil
10.6.2.1. Key country dynamic
10.6.2.2. Regulatory framework
10.6.2.3. Competitive insights
10.6.2.4. Brazil Precision Medicine Software market estimates and forecasts, 2021 - 2033 (USD Million)
10.6.3. Argentina
10.6.3.1. Key country dynamic
10.6.3.2. Regulatory framework
10.6.3.3. Competitive insights
10.6.3.4. Argentina Precision Medicine Software market estimates and forecasts, 2021 - 2033 (USD Million)
10.7. MEA
10.7.1. MEA Precision Medicine Software market estimates and forecasts, 2021 - 2033 (USD Million)
10.7.2. South Africa
10.7.2.1. Key country dynamic
10.7.2.2. Regulatory framework
10.7.2.3. Competitive insights
10.7.2.4. South Africa Precision Medicine Software market estimates and forecasts, 2021 - 2033 (USD Million)
10.7.3. Saudi Arabia
10.7.3.1. Key country dynamic
10.7.3.2. Regulatory framework
10.7.3.3. Competitive insights
10.7.3.4. Saudi Arabia Precision Medicine Software market estimates and forecasts, 2021 - 2033 (USD Million)
10.7.4. UAE
10.7.4.1. Key country dynamic
10.7.4.2. Regulatory framework
10.7.4.3. Competitive insights
10.7.4.4. UAE Precision Medicine Software market estimates and forecasts, 2021 - 2033 (USD Million)
10.7.5. Kuwait
10.7.5.1. Key country dynamic
10.7.5.2. Regulatory framework
10.7.5.3. Competitive insights
10.7.5.4. Kuwait Precision Medicine Software market estimates and forecasts, 2021 - 2033 (USD Million)
Chapter 11. Competitive Landscape
11.1. Participant Overview
11.2. Company Market Position Analysis/Company Market Share Analysis, (2024)
11.3. Company Categorization
11.4. Strategy Mapping
11.5. Company Profiles/Listing
11.5.1. OSP
11.5.1.1. Overview
11.5.1.2. Financial performance
11.5.1.3. Product benchmarking
11.5.1.4. Strategic initiatives
11.5.2. Genomind
11.5.2.1. Overview
11.5.2.2. Financial performance
11.5.2.3. Product benchmarking
11.5.2.4. Strategic initiatives
11.5.3. IQVIA
11.5.3.1. Overview
11.5.3.2. Financial performance
11.5.3.3. Product benchmarking
11.5.3.4. Strategic initiatives
11.5.4. Genedata AG
11.5.4.1. Overview
11.5.4.2. Financial performance
11.5.4.3. Product benchmarking
11.5.4.4. Strategic initiatives
11.5.5. SOPHiA GENETICS
11.5.5.1. Overview
11.5.5.2. Financial performance
11.5.5.3. Product benchmarking
11.5.5.4. Strategic initiatives
11.5.6. Tempus AI, Inc.
11.5.6.1. Overview
11.5.6.2. Financial performance
11.5.6.3. Product benchmarking
11.5.6.4. Strategic initiatives
11.5.7. Owkin, Inc.
11.5.7.1. Overview
11.5.7.2. Financial performance
11.5.7.3. Product benchmarking
11.5.7.4. Strategic initiatives
11.5.8. Syapse (acquired by N-Power in January 2025)
11.5.8.1. Overview
11.5.8.2. Financial performance
11.5.8.3. Product benchmarking
11.5.8.4. Strategic initiatives
11.5.9. Inspirata, Inc.
11.5.9.1. Overview
11.5.9.2. Financial performance
11.5.9.3. Product benchmarking
11.5.9.4. Strategic initiatives
11.5.10. Precision Medicine Group, LLC.
11.5.10.1. Overview
11.5.10.2. Financial performance
11.5.10.3. Product benchmarking
11.5.10.4. Strategic initiatives
11.5.11. Siemens
11.5.11.1. Overview
11.5.11.2. Financial performance
11.5.11.3. Product benchmarking
11.5.11.4. Strategic initiatives
11.5.12. GenomOncology LLC
11.5.12.1. Overview
11.5.12.2. Financial performance
11.5.12.3. Product benchmarking
11.5.12.4. Strategic initiatives
11.5.13. Qserve
11.5.13.1. Overview
11.5.13.2. Financial performance
11.5.13.3. Product benchmarking
11.5.13.4. Strategic initiatives
11.5.14. Foundation Medicine, Inc.
11.5.14.1. Overview
11.5.14.2. Financial performance
11.5.14.3. Product benchmarking
11.5.14.4. Strategic initiatives
11.5.15. PierianDx
11.5.15.1. Overview
11.5.15.2. Financial performance
11.5.15.3. Product benchmarking
11.5.15.4. Strategic initiatives
관련자료
